An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptor

This publication has 26 references indexed in Scilit:

• Molecular Mechanisms of Resistance to Tamoxifen Therapy in Breast Cancer
  Archives of Surgery, 1993
• Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER
  Molecular Endocrinology, 1992
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Potential Role of Tamoxifen in Prevention of Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Solution Structure of the Glucocorticoid Receptor DNA-Binding Domain
  Science, 1990
• Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation
  Cell, 1988
• The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
  Cell, 1988
• The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function
  Cell, 1988
• Functional domains of the human estrogen receptor
  Cell, 1987
• The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer
  Cancer, 1980